ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #69Top JournalHybrid

Lancet Diabetes & Endocrinology

Acronym:thelancetde
•
Abbreviation (ISO):LANCET DIABETES ENDO
•
Identifier (ISSN):2213-8587(Print)/2213-8595(Online)
•
Publisher:Elsevier BV
Clarivate IF (2026)
36.3↓ -5.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Lancet Diabetes & Endocrinology

WoS Q1
1328435819.3201824.5201925.3202032.1202144.9202244.5202344.0202441.8202536.32026
Annual Impact Factor Metric
Current (2026):36.3
Scopus SJR & RankScopus Q1
11.61
#69

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
207

207 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
62articles/year
18.46% Gold OA•84.21% Original Research

Aims & Scope

Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.

Topics Covered (Recognized by AI)
Medicine91.4%Biology88.2%Endocrinology70.4%Internal medicine64.6%Chemistry57.1%Biochemistry55.4%Diabetes mellitus47.1%Political science46.9%Law46.7%Pathology44.6%MEDLINE40.9%Intensive care medicine28.7%Type 2 diabetes24.9%Genetics22%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank3/198
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank1/198
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF36.3
Articles / Year131
Total Citations179
2025
IF41.8
Articles / Year220
Total Citations4,562
2024
IF44
Articles / Year202
Total Citations5,100
2023
IF44.5
Articles / Year212
Total Citations6,899
2022
IF44.867
Articles / Year196
Total Citations14,262

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #69Scopus Q1SCImago Profile
Scopus Coverage:2013-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
11.61

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
9.10

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$5,128 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations6,586
3-Year Documents575
Citable Documents191

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ1
Endocrinology, Diabetes and MetabolismQ1
Internal MedicineQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Lancet Diabetes & Endocrinology (acronym: thelancetde, abbr: LANCET DIABETES ENDO, ISSN: 2213-8587) is a peer-reviewed international scholarly journal in the field of ENDOCRINOLOGY & METABOLISM, published by Elsevier BV in England. The periodical holds a Journal Impact Factor (JIF) of 36.3, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 11.6 (Q1), an H-index of 207.

The journal enforces rigorous peer evaluation with an annual output of approximately 62 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $5,128 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier BV
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: fe25339c-8529-4e1b-a9b8-d17ad2200949
Database Updated: 2026-10-16